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Abstract
Matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) has
emerged as a novel powerful MS methodology that has the ability to generate both molecular and
spatial information within a tissue section. Application of this technology as a new type of
biochemical lipid microscopy may lead to new discoveries of the lipid metabolism and biomarkers
associated with area-specific alterations or damage under stress/disease conditions such as
traumatic brain injury or acute lung injury, among others. However there are limitations in the
range of what it can detect as compared with liquid chromatography-MS (LC-MS) of a lipid
extract from a tissue section. The goal of the current work was to critically consider remarkable
new opportunities along with the limitations and approaches for further improvements of MALDI-
MSI. Based on our experimental data and assessments, improvements of the spectral and spatial
resolution, sensitivity and specificity towards low abundance species of lipids are proposed. This
is followed by a review of the current literature, including methodologies that other laboratories
have used to overcome these challenges.
© 2012 Elsevier Ireland Ltd. All rights reserved.
*Address correspondence and reprint requests to Drs. L.J. Sparvero or Valerian E. Kagan, Center for Free Radical and Antioxidant
Health, Department of Environmental and Occupational Health, University of Pittsburgh, Bridgeside Point, 100 Technology Drive,
Suite 350, Pittsburgh, PA 15219-3130, USA, kagan@pitt.edu, ljs39@pitt.edu, Phone:+1.412.624.9479, Fax: +1.412.624.9361.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Author emails:
LJS, ljs39@pitt.edu; AAA, amoscatoaa@upmc.edu; CED, dixoec@upmc.edu; JBL, joseph.long@us.army.mil; PMK,
kochanekpm@ccm.upmc.edu; BRP, brucep@pitt.edu; HB, bayihx@ccm.upmc.edu; VEK, kagan@pitt.edu
NIH Public Access
Author Manuscript
Chem Phys Lipids. Author manuscript; available in PMC 2013 July 01.
Published in final edited form as:
Chem Phys Lipids. 2012 July ; 165(5): 545–562. doi:10.1016/j.chemphyslip.2012.06.001.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Keywords
Lipidomics; MALDI imaging; Traumatic brain injury; Acute lung injury; Lipid peroxidation;
Docosahexaenoic acid
1. INTRODUCTION
“It is always wise to look ahead, but difficult to look further than you can see.”
Winston Churchill
1.1 Multiple roles and molecular diversity of phospholipids and their oxidation products
Lipids are fundamental components of tissue architecture and are critical for tissue function.
According to current estimates, the mammalian lipidome is comprised of 10,000 to 100,000
individual species of lipid molecules (Schuhmann et al., 2011) making it more diversified
than the proteome or genome. This remarkable diversity of tissue-specific lipids originates
from a few hundred lipid classes, including phospholipids (PLs), glycolipids, sphingolipids,
and neutral lipids (Shevchenko and Simons, 2010). Phospholipids in particular consist of a
headgroup, a phosphoester-connected glycerol backbone, and (usually ester-linked) two
fatty acid chains. Different headgroups distinguish different phospholipid classes. These
headgroups tend to be exposed to the aqueous environment while the hydrophobic fatty acid
chains are usually embedded in cellular and subcellular membranes. There are over 15
common fatty acid residues that exist in varying combinations in different phospholipids.
One notable exception from this general plan of architecture is cardiolipin (CL), a
phospholipid that contains four fatty acid chains and is found exclusively in mitochondria.
Its molecular diversity can thus be much larger. Most tissues such as lung, liver, and heart
have only a few major species of CL in high abundance (Minkler and Hoppel, 2010). Brain
tissue, on the other hand, is extremely diverse with respect to the number of CL species. A
typical CL spectrum of murine brain exhibits approximately 10-12 major CL clusters, most
of which have multiple individual CL species at several isobaric masses. This gives over
eighty major molecular species of brain CL, all at relatively similar abundances (Kiebish et
al., 2008) (Bayir et al., 2007) (Tyurin et al., 2008a) (Sparvero et al., 2010) (Samhan-Arias et
al., 2012).
In addition to their structural role in membranes, polyunsaturated lipids are precursors of
important signaling molecules that are formed by multistage oxygenation of polyunsaturated
fatty acid residues (PUFAs) – linoleic (C18:2), arachidonic (C20:4), eicosapentaenoic
(C20:5), docosapentaenoic (C22:5) and docosahexaenoic (C22:6) acids (Guichardant et al.,
2011). Usually, phospholipase A2—catalyzed hydrolysis precedes the enzymatic
oxygenation stages and represents a rate-limiting stage in the overall biosynthetic process. A
huge number of different oxygenated fatty acids formed via this general pathway act as
potent intra- and extracellular regulators of multiple biological functions (Marcheselli et al.,
2003). Alternatively, esterified fatty acid residues of phospholipids that contain multiple
double bonds are prone to oxidative modifications yielding predominantly hydroperoxy-,
hydroxy-, epoxy- and oxo-functionalities to phospholipids (Domingues et al., 2008) (Fuchs
et al., 2011) (Kim et al., 2011). Phospholipids with oxidized fatty acid residues can undergo
subsequent hydrolysis by specialized phospholipases – e.g., lipoprotein lipase A2 – to yield
oxygenated fatty acids and lyso-phospholipids (Vaishnav et al., 2010). The oxidatively
modified phospholipids can also generate a number of secondary degradation products with
truncated fatty acid chains (Tyurin et al., 2009) (Yin et al., 2011) (Liu et al., 2011) (Hall et
al., 2010). Peroxidation of polyunsaturated phospholipids may occur as a random – likely
non-enzymatic - free radical oxidation commonly associated with oxidative stress and injury
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(Girotti, 1998) (Hall et al., 2004) (Singh et al., 2006). This type of oxidative damage can
result from a variety of insults, including overload with catalytic transition metals (Valko et
al., 2005), chemical poisoning with carbon-tetrachloride (Weber et al., 2003), and ischemia/
reperfusion (Zhang et al., 1996). In many cases, phospholipid peroxidation and tissue
damage and cell death can be selective whereby different phospholipids undergo oxidative
modification at different rates (Tyurin et al., 2008b).
Two anionic phospholipids - a mitochondria-specific CL and extra-mitochondrial
phosphatidylserine (PS) - are the most reactive to oxidative stress during apoptotic cell death
(Tyurin et al., 2008a) (Korytowski et al., 2011). Of the many polyunsaturated fatty acid
chains that these phospholipids exhibit, only a select few are prone to biological oxidative
modification during apoptosis (Sparvero et al., 2010) due to the involvement of a specific
catalyst, cytochrome c, in the oxidation process (Kagan et al., 2005) (Tyurin et al., 2010).
While these features of random (non-enzymatic) and selective (enzymatic) peroxidation
reactions have been known for a long time, their spatial confinements to specific regions and
to specific types of cells and subcellular compartments have not been definitively
established. This is mostly due to the insufficiency of methodological approaches for the
detailed and accurate mapping of lipids and lipid oxidation products in tissues.
1.2 Mass Spectrometry and matrix-assisted laser desorption/ionization (MALDI) imaging in
lipidomics
Mass Spectrometry (MS) has emerged as the analytical technology with sufficient sensitivity
and specificity to quantitatively analyze the complexities of biological materials at the
molecular level (Gross, 2011) (Murphy et al., 2011b). The advent of soft ionization
technologies (laser desorption or electrospray ionization) enabled mass spectra of biological
molecules (proteins, lipids, etc) to be obtained. Coupling MS to separation techniques (such
as liquid chromatography (LC)) and selective fragmentation by tandem mass spectrometry
(MS/MS) markedly improves the analysis of complex mixtures. MALDI and electrospray
ionization (ESI) are two of the most prominent soft-ionization MS methods for the direct,
label-free analysis of intact lipids and each has its own strengths and limitations (Fuchs et
al., 2010) (Han et al., 2012). MALDI analysis can be performed on intact tissue sections
(MALDI imaging or MALDI-MSI1) to provide spatial localization for various lipid species,
while ESI-LC-MS of lipid extracts allows for a global assessment of lipid species (Delvolve
et al., 2011) (Goto-Inoue et al., 2011) (Zemski-Berry et al., 2011) (Fernández et al., 2011)
(Amstalden van Hove et al., 2010). Although lipid extracts are devoid of spatial information,
microdissected regions of interest within a tissue section and their subsequent extraction can
determine localization of lipid species (Burnum et al., 2009) (Hankin and Murphy, 2010).
Once an array of MALDI mass spectra is obtained using a pulsed laser across a tissue
section, it is possible to create a lipid-ion image that is associated with a particular mass-to-
charge (m/z) ratio. This image represents the spatial distribution and relative abundance of
that particular lipid-ion, and can be correlated with histological features (Burnum et al.,
2009) (Delvolve et al., 2011) (Carter et al., 2011). By adding internal standards, absolute
abundances of several lipid classes can be measured with high precision using MALDI-MSI
(Landgraf et al., 2011). MALDI-MSI does not require specific antibodies such as those used
in immunohistochemical methods. This allows for direct analysis and discovery of
molecular species. In contrast to radioactive or fluorescent labeling-based techniques, one is
not limited to a small number of detectable species. Breakdown products (including
lysophospholipids and oxidatively modified species) are also detectable as distinct
molecular species (Koizumi et al., 2010) (Wang et al., 2010).
1We have chosen to use “MALDI-MSI” although both it and “MALDI-IMS” are used by many authors in the field.
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Substantial progress has been made in the field of MALDI-MSI of lipids; however, there are
still many unresolved issues that need to be addressed (Lagarrigue et al., 2011). While
MALDI-MSI is a unique source of valuable information on spatial distribution of lipids,
issues on the completeness of the assessments of the lipidome it yields and the overall
quantitative aspects of lipid MSI-maps still await further study. One of the important
limitations of MALDI-MSI that is observed but not often discussed is that it detects fewer
species of lipids than ESI-LC-MS. Reasons include ion suppression by highly abundant lipid
species, uncontrolled in-source decay (ISD), specific matrix requirements for successful
MALDI-MSI and the ambiguity of some lipid species with respect to mass. Although highly
abundant classes of lipids such as phosphatidylcholine (PC) correlate well between MALDI-
MSI and ESI-LC-MS, species from less abundant classes such as phosphatidylethanolamine
(PE) do not (Hankin and Murphy, 2010). One of the useful approaches may be based on
comparative studies of spectra from MALDI-MSI of lipids in a tissue section to those
obtained by traditional LC-MS analyses of lipid extracts from serial sections. By using these
comparisons, in the current study we attempted to evaluate the advantages and limitations of
MALDI-MSI in a more quantitative way and offer suggestions to potentially overcome
certain limitations and ambiguities in applying this powerful technology for the spatial
analysis of lipids and their oxidative metabolism. Two types of tissue samples - the brain
and the lung – have been employed to illustrate current limitations and possible approaches
to circumvent them as well as potential perspectives in the applications of MALDI-MSI of
phospholipids. The methodologies covered in the Discussion section are not just the
examples from our own laboratory (as illustrated in the Results section) but also include
many other techniques developed by other groups. This will be particularly useful for the
newcomers since MSI is a relatively new field of both mass spectrometry and lipidomics.
Inevitably this resulted in a “hybrid” type of paper that combines features of an original
contribution with those of a review.
2. RESULTS
2.1 MALDIMSI in negative and positive modes: regional correlation with phospholipid and
sphingolipid abundances
Negative-mode MALDI-MSI of naïve adult mouse brain detected a variety of anionic
phospholipid species and sphingolipids as [M-H]−anions (fig. 1). At a spatial resolution of
50μm, MALDI-MSI displayed clear species-specific mapping of certain lipids to particular
anatomical regions of the brain as compared with a serial H&E tissue section. MALDI-MSI
indicated that many sulfatide (ST) species including ST(d18:1/24:1) were more abundant in
the white matter than in the hippocampus or cortex, while the opposite was the case for
several phospholipid species including PI(18:0/20:4). The ion at m/z 834.5, which is isobaric
for PS(40:6) and ST(d18:1/20:0), appeared across the whole brain section while the ion at
m/z 806.5, which is isobaric for PS(38:6) and ST(d18:1/18:0), was localized to the white
matter. Two PI species - PI(38:4) and PI(36:4) - represented the most abundant phospholipid
species detected in negative mode.
Two serial brain sections from naïve, postnatal day 17 (pnd 17) rat were prepared and
imaged in both positive and negative mode for a global analysis of phospholipid species.
Several phosphatidylcholine (PC) species including PC(16:0/16:0) and PC(16:0/18:1) were
detected as various adducts ([M+H]+, [M+Na]+, and [M+K]+) and these adducts were
considered to be only one phospholipid species even though they occur at a different m/z
values. Overall, from both modes a total of 48 species of lipids from various classes
including 18 species of phospholipids were detected (table 1).
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2.2 Missing classes of lipids with MALDI-MSI: comparison with MALDI-MS and ESI-LC-MS
of lipid extracts
Of the 48 species of lipids detected with MALDI-MSI, there were several lipids that are
known to be present in the brain that were not detected using this technology. PA and PG
species occur in low abundance in the brain and were not readily detected by MALDI-MSI.
Another phospholipid that was under-represented/not detected was CL. There are normally
over eighty detectable molecular species of brain CL, but MALDI-MSI only observed 10,
and this was achieved only after the tissue was treated with phosopholipase C (table 2 and
see section 2.3 below).
To obtain a better understanding of the relatively low representation of many diverse lipid
species in MALDI-MSI-maps of the brain, we compared MALDI-MSI data to those
obtained by ESI-LC-MS analysis of lipid extracts obtained from serial sections from brain
tissue. We reasoned that the lipid distribution of a section of tissue was approximately
similar in both of its serial sections. If the lipid extract and serial-section tissue section are
analyzed by MS methods (ESI-LC-MS and MALDI-MSI as appropriate), then a direct
comparison can be made (Burnum et al., 2009) (Hankin and Murphy, 2010) (Koeniger et al.,
2011) (Delvolve et al., 2011).
Using negative mode MALDI, similar results between MALDI-MS and MALDI-MSI were
seen (table 1). The most prominent classes of lipids seen in MALDI-MS were ST, PI and
gangliosides, similar to MALDI-MSI. Positive mode MALDI-MS also yielded similar
results to MALDI-MSI with the only significant change being a reduction in the intensity of
some salt adducts. As with MALDI-MSI, Cer(d18:1/18:0) was the only species from its
class that was detected by MALDI-MS in a total lipid extract, and its intensity was divided
between [M-H2O+H]+ and [M+Na]+ adducts. Although the total lipid extract significantly
purifies and concentrates low abundant species such as CL, it also concentrates other
phospholipid species that contribute to CL signal suppression. In general, species that were
under-represented with MALDI-MSI were likewise under-represented with MALDI-MS of
the total lipid extract.
A comparison of ESI-LC-MS assessments of individual molecular species of lipids from
serial tissue sections to lipid species detected by MALDI-MSI is presented in Table 1. It is
apparent that MALDI-MSI was able to detect (and localize) only a relatively small fraction
(~25%) of the total number of lipid species identified by ESI-LC-MS. Even when the results
from positive- and negative-mode MALDI-MSI are combined, several classes of lipids are
missing or under-represented. While some species of PE and PS might be detected in
positive mode MALDI-MS as adduct masses isobaric to certain PC species (Hsu and Turk,
2005) (Garrett et al., 2007), our LC-MS analysis did not identify any such species. Only 10
species of CL were detected by MALDI-MSI (only after treatment of the tissue with
phospholipase-C (PLC), see section 2.3 below) as opposed to 70 detected by ESI-LC-MS.
There are several major reasons for the more limited detection of lipids by MALDI-MSI vs.
LC-MS. To attempt to improve and enrich the representation of different lipids in MALDI-
MSI we used several approaches as described in sections 2.3-2.6 below.
2.3 Treatment of tissue sections with phospholipases to reduce ion suppression in MALDI-
MSI
In order to enhance the number of lipid species detected, we reasoned that treatment of the
tissue with PC-specific phospholipase-C (PLC) prior to matrix deposition and MALDI-MSI
may be an advantageous approach. PC is a highly abundant group of lipid species that can
contribute to ion suppression (Schiller et al., 2002) (Johanson et al., 2007). This enzyme
cleaves the head group of PC converting it to diacylglycerol (DAG) which has not been
Sparvero et al. Page 5
Chem Phys Lipids. Author manuscript; available in PMC 2013 July 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
reported to contribute to ion suppression. Indeed, treatment of naïve pnd 17 rat brain tissue
with PLC prior to MALDI-MSI allowed an improvement in the detection of several CL
species (figs. 2 and 3). However, this only partially resolved the issue of ion suppression.
Other higher abundance lipid species that dominate the spectra in the negative mode include
PI, PS and gangliosides, and these compete for negative charges with the less abundant
species such as CL. In addition, some of these species such as ganglioside GM1
(d18:1/20:0) at m/z 1544.8 are in the same mass range as brain CL (m/z 1400-1600) and can
significantly mask signals from isobaric CL species. Here, ESI-LC-MS has an advantage by
its ability to separate individual classes of lipids, resulting in greater sensitivity for low
abundance CL species.
2.4 Isobaric masses in MALDI-MSI: Identification of with the aid of ESI-LC-MS and high-
mass resolution analyzers (FT-ICR)
Normal phase LC-MS also can be used to resolve isobaric lipid species seen in MALDI-MSI
(fig. 4) by its ability to separate individual classes of phospholipids. A typical example is
related to the previously mentioned (section 2.1) ions at m/z 806.5 and m/z 834.5 (negative
mode) in murine brain that were isobaric for ST and PS species. Therefore each of those
signals could represent PS, ST, or some combination of both. When the brain total lipid
extract is separated by LC-MS, the ST and PS fractions elute at 4 min and 25 min,
respectively. The spectrum of each of those fractions was examined for those two masses,
and the ion at m/z 834.5 was present in both the ST and PS fractions while the ion at m/z
806.5 was present in the ST fraction with a very minimal signal seen in the PS fraction.
Therefore the identity of the ion at m/z 806.5 from the MALDI image was mostly ST, while
the ion at m/z 834.5 was a mixture of PS and ST at similar abundances.
Another approach to overcome the problem of isobaric masses in MALDI-MSI is through
the use of high resolution FT-ICR analyzers. Although time of flight (TOF) instruments are
often used for MALDI-MSI, they are not the only option. FT-ICRs, Orbitraps and other high
mass resolution instruments can be fitted with MALDI sources and utilized for imaging, and
such high-mass resolution spectra can be directly compared to sections analyzed with TOF
instruments (Burnum et al., 2009). Performing MALDI-MSI with an FT-ICR instrument
will result in considerably better mass accuracy and resolution than if a TOF instrument was
used (fig. 5).
2.5 Limitations on spatial resolution of MALDI-MSI: oversampling for high spatial
resolution
The diameter of the laser footprint usually places a limitation on the spatial resolution of
MALDI-MSI of approximately 30×30 microns. However MALDI-MSI can be performed
with a spatial resolution less than the diameter of the laser footprint by using oversampling-
stepping (Jurchen et al., 2005). Utilizing this methodology, MSI of lipids can approach near-
cellular resolution. An example illustrating the application of this to mapping lipids in the
hippocampus is presented in figure 6. ST, PI, and gangliosides were still seen as the main
species in negative mode, but their various co-localizations in different regions of the
hippocampus were determined more precisely. ST(d18:1/24:0) was strongly localized to
nearby vessels and in moderate abundance within the CA3 region, while ganglioside GM1
and PI(18:0/20:4) were almost entirely the opposite. Within the CA3 and dentate gyrus,
GM1 and PI(18:0/20:4) were stronger in intensity on different layers.
Spectra approaching cellular resolution were determined by close comparison of the MALDI
image to the tissue section. For these types of studies, the laser was set to dwell for repeated
shots on each location resulting in the center of the beam ablating not only the matrix but
also a small part of the tissue itself. Subsequent to MALDI-MSI, the actual tissue section
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(not a serial section in this case) was H&E stained, and the laser ablation marks were easily
seen (fig. 6). Since each pixel in a MALDI image corresponds to a physical location on the
tissue, the image corresponded exactly to the histological features of the tissue. Each pixel is
a complete MALDI spectrum of one location. Because the tissue sections for MALDI-MSI
are relatively thick (usually 8-12 microns), the analyte extraction and desorption process
may involve more than one layer of cells thus setting a limit to near-celluar resolution (see
section 3.2).
2.6 MALDI-MSI reveals physiologically- and pathologically-relevant changes of lipids in
tissues
In spite of significant limitations inherent to current MALDI-MSI protocols, the analytical
power of this emerging technology may be sufficient for revealing important site-specific
changes in lipid molecular speciation in the tissues. To illustrate the potential of MALDI-
MSI we present our results that have led to building lipid maps of the brain and lung tissue
after several physiologically or pathologically relevant treatments. As illustrated by the data
shown in figures 7, 8 and 9, we were able to reveal region-specific changes in the molecular
species of lipids in brain and lung.
2.6.1 MALDI-MSI of brain tissue after DHA supplementation—Docosahexaenoic
acid (DHA) is an essential polyunsaturated fatty acid in the central nervous system (CNS)
and it has been reported to possess neuroprotective effects (Belayev et al., 2009) (Niemoller
and Bazan, 2010). Both PS and CL consist of several molecular species that contain
esterified DHA. The major species of DHA-containing PS in the brain is PS(18:0/22:6), and
there are many diverse DHA-containing CL species that we have determined previously
(Tyurin et al., 2009). We assumed that after i.p. injection of DHA as a free fatty acid the
majority of supplemental DHA would become esterified into different classes of
phospholipids resulting in very low levels of free DHA remaining in the brain. The identity
of those phospholipids was determined and quantitatively assessed by MALDI-MSI and
ESI-LC-MS (fig. 7). The effectiveness of DHA esterification into PS and CL resulted in a
much greater abundance of DHA-PS and DHA-CL is illustrated by figure 7.
2.6.2 Detection of lipid peroxidation products by MALDI-MSI—Lipid peroxidation
products are usually present in very low abundance and hence are particularly difficult to
detect by MALDI-MSI. One can envision two major options to detect the changes
associated with oxidative lipid modifications: 1) direct detection of peroxidized lipids or
their oxidation products, and 2) indirect documentation of the decreased content of
polyunsaturated lipids, the major substrates of lipid peroxidation. The latter protocol may
benefit from cumulative monitoring of the disappearance of polyunsaturated species each of
which may be converted into a plethora of oxidation products with expectedly very low
levels of newly generated oxygenated molecular species.
2.6.2.1 Regional assignment of major phospholipid classes and detection of less
abundant cardiolipin oxidation products by MALDI-MSI in acute lung injury (ALI):
In contrast to brain, lung presents a number of unique challenges in MALDI-MSI including:
a) heterogeneous multicellular architecture places a premium on high resolution imaging to
approach complexities of cellular function; and b) traditional requirement for both inflation
and embedding of nonrigid lung to facilitate thin sectioning may introduce chemicals known
to be incompatible with MALDI-MSI (Berry et al, 2011). Although both brain and lung CL
are present in low abundances, the majority of lung CL is concentrated into less than a dozen
molecular species, many of which are enriched in linoleic (C18:2) acid (Tyurina et al.,
2010). Since each species of CL can produce a broad range of oxidatively modified
products, starting with fewer species of CL will potentially improve the possibility of
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detection of their oxidized products. Accordingly, we approached aspects of uniqueness of
lung phospholipid analysis by MALDI-MSI, by following lead of Berry et al (2011) and: a)
preserved architecture with a modified OCT embedding agent followed by oversampling for
high spatial resolution MSI; and b) acutely injuring a limited segment (upper airways) of
lung of intact mice and focused on predicted changes in CL including its oxidative products
(Tyurina et al, 2010; Tyurina et al, 2011).
Mouse lungs were inflated with modified OCT (Berry et al., 2011) and a section was
examined by negative mode MALDI-MSI followed by light microscopy (fig. 8A). Although
several species of phospholipids - PS, PI, PG - were uniformly detected, CL was not. This
result was not surprising, considering the abundance of PC in lung and its ability to suppress
the signals of lower-abundance phospholipids (see sections 2.2-2.3 above).
In order to analyze CL, MALDI-MSI of naive lung tissue was performed on sections treated
with PLC (figs. 8B and 8C). A limited number of clusters of CL (in contrast to brain) were
detected and their m/z corresponded to our recent reports (Tyurina et al., 2010) (Tyurina et
al., 2011) from whole lung homogenates. After intratracheal instillation of a strong pro-
oxidant system of glucose oxidase, lactoperoxidase + D-glucose (Johnson et al., 1981) that
readily causes acute injury to upper airway epithelium, MALDI-MSI with PLC treatment
revealed a large number of detectable oxidatively degraded (truncated) CL species (figs. 8D,
8E, and 8F). Beta-scission is the process of non-enzymatic, homolytic cleavage of
peroxidated lipids (Picariello et al., 2009), and this produces a wide variety of truncated
products. For example, each peroxidized linoleic (C18:2) fatty acyl chain can undergo beta
scission resulting in both a truncated chain attached to the oxidized CL and the formation of
4-hydroxynonenal (4-HNE) or 4-hydroxyhexenal (4-HHE). These truncated-CLs will appear
at m/z 1300-1400, a mass range that is normally devoid of lipid species. For example, TLCL
(m/z 1448) with either a hydroxy-modification (+16 Da) or a peroxy-modification (+32 Da)
could undergo beta scission with the formation of 4-HNE resulting in truncated species at m/
z 1308 and 1324, respectively. Likewise, CL(74:10) and CL(74:9) at original m/z values
1472 and 1474 could undergo peroxy- or dihydroxy-modifications that would undergo beta
scission with the formation of either 4-HNE or 4-HHE resulting in truncated species at m/z
1348 or 1392, respectively. Our previously published work indicated that lung CL species at
m/z values of 1448, 1472 and 1474 contained at least one or more oxidizable fatty acyl
chains (Tyurina et al., 2010). These few species of lung CL could potentially yield many
oxidized species in the m/z 1300-1400 mass range. In initial MALDI-MSI experiments at a
resolution of 50 μm, we detected small amounts of CL and a variety of oxidatively degraded
CL in glucose oxidase treated airway epithelium (fig. 8F). To the best of our knowledge, this
is the first in situ demonstration of this lower abundance PL in lung and also reveals the
ability of MALDI-MSI in detecting oxidized species of CL and assigning critical anatomic
location in experimental acute lung injury.
To more accurately assess regional distribution of the most common phospholipids, PC, a
lung section from a naïve young-adult male mouse was examined by positive mode
MALDI-MSI with both normal spatial resolution (figure 8G) and oversampling (figure 8H)
followed by light microscopy. Lung phospholipids are dominated by PC and a major
species, PC(16:0/16:0), contributes significantly to specialized airway lining fluid or
surfactant, critical in preventing lung collapse during respiratory cycle. As noted in figure
8G, PC(16:0/16:0) with m/z 734.5 is distributed uniformly through distal lung. In contrast,
the less abundant PC(16:0/22:6) with m/z 806.6 appears in a distinct compartment (fig. 8G).
This localization is evident by overlaying the oversampling MALDI-MSI images of
PC(16:0/16:0) (green) and PC(16:0/22:6) (red) in figure 8H. On closer examination this is
associated with upper airway epithelium as confirmed by subsequent light microscopy of the
tissue section. These findings are consistent with biochemical analyses of Bernhard et al
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(1997) who suggested that the alveolar origin of PC(16:0/16:0) was the source of this
common saturated PL uniformly distributed throughout surface lining material of lung. This
was in contrast to PL composition of upper airway epithelium, per se (and perhaps
underlying connective tissue) that was enriched in PUFA-containing PL including
PC(16:0/22:6) (Bernhard et al., 1997). The oversampling approach facilitated resolution to
20 μm allowing us to identify airway epithelium as the likely cellular source of PUFA-
containing PC and conforming to the slightly lower resolution (approximately 50 μm)
predictions of Berry et al (2011) that arachidonic acid- (and docosohexaenoic acid-)
containing PC may be the source of precursors for important oxygenated lipid signaling
pathways in lung. Imaging MS has revealed other important aspects of complex PC
composition in regional components of kidney (Kaneko et al., 2011) and retina (Hayasaka et
al., 2008).
2.6.2.2 Decreased content of oxidizable polyunsaturated lipids: MALDI-MSI in
traumatic brain injury (TBI): MALDI-MSI was used to analyze regional differences in
PL distribution resulting from TBI. Two hours after CCI, coronal serial-sections were taken
at the site of impact from pnd 17 rats for analysis in both positive and negative modes. There
are two major ions in negative mode (m/z 806.5 and m/z 834.5) that are each isobaric for a
PS and a ST species (fig. 9). Total lipid extracts from serial sections followed by LC-MS
already have determined that the ion at m/z 806.5 is almost entirely ST(d18:1/18:0) with a
small amount of oxidizable PS(16:0/22:6) while the ion at m/z 834.5 is a mixture of similar
amounts of ST(d18:1/20:0) and oxidizable PS(18:0/22:6). MALDI-MSI determined that the
ion at m/z 806.5 (mostly ST and localized to white matter) displayed no detectable change in
the impact region. However the ion at m/z 834.5 displayed a decreased intensity in the
cortical impact region but almost no change in the white matter. Other ST species did not
change. Interestingly, these ST species localized predominantly to the white matter region
and not the cortex, while only the ambiguous ion at m/z 834.5 displayed localization to both
white matter and cortex. Therefore we concluded that the decrease in the ion at m/z 834.5
represented the loss of PS(18:0/22:6) but not its isobaric species ST(d18:1/20:0). In the brain
both PS(16:0/22:6) and PS(18:0/22:6) contain a polyunsaturated DHA, and are susceptible
to oxidative attack (Bayir et al., 2007). The former is in significantly less abundance than the
latter. This confirms that the ion at m/z 806.5 is mostly ST, and the ion at m/z 834.5 is
predominantly PS, and also indicates that PUFA-containing PS is diminished in the
ipsilateral cortical and hippocampal regions in CCI. Concurrent loss of oxidizable
PI(18:0/20:4) was detected in those regions as well. Although the total abundance of non-
oxidizable PL species (such as PC(16:0/16:0), detected in positive mode on a serial section)
did not change, as expected some displayed different adduct abundances within and outside
the impact region (Hankin et al., 2011).
3. DISCUSSION
While MALDI-MS and ESI-MS represent a “gold standard” for lipid analysis at the
molecular level, MALDI-MSI has recently become another critically important MS method
that has added another dimension to the MS analysis of biomolecules allowing for molecular
and spatial information to be correlated within a tissue section (reviewed in (Chaurand et al.,
2011)). Several important MALDI-MSI papers have documented injury-associated changes
in several types of lipids, including lysophosphatidylcholines, ceramides, gangliosides in
brain injury models (Koizumi et al., 2010) (Hankin et al., 2011) (Whitehead et al., 2011).
Murphy et al performed MALDI-MSI on lung tissue prepared with a MALDI-compatible
embedding compound and demonstrated localization of PUFA-containing phospholipids to
airways (Berry et al., 2011)
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3.1 How many species of phospholipids do we “see” by MALDI-MSI?
Due to the high content and diversity of lipids in the CNS, brain tissue sections became one
of the most common objects for MALDI-MSI (Delvolve et al., 2011). CNS tissue has the
highest lipid content next to adipose tissue (Han, 2007). Groundbreaking work on lipid
imaging identified 32 molecular species of phospholipids and sphingolipids in brain tissue
(Jackson et al., 2007a). MALDI-MSI has been used to analyze a variety of brain lipids,
including gangliosides, sulfatides, and phosphatidylcholines (Zemski-Berry et al., 2011).
However there are obvious deficiencies in MALDI-MSI that warrant further methodological
improvements. One of the significant limitations of MALDI-MSI is that it detects fewer
species of some phospholipid classes than ESI-LC-MS (Hankin and Murphy, 2010). Our
results demonstrate that ESI-LC-MS, when performed on serial sections of the brain in
conjunction with MALDI-MSI, elucidates more information about lipids and their spatial
localization than is possible with either technique alone. In normal brain tissue,
approximately 25% of lipid molecular species detectable by ESI-LC-MS can be mapped by
MALDI-MSI. Similarly, MALDI-MSI accounts for only a relatively small fraction of total
brain lipids seen after DHA supplementation or TBI. In the lung, ESI-LC-MS detects ~100
molecular species of phospholipids, while only ~40 species are revealed by MALDI-MSI.
Therefore, it is important to identify the major factors that contribute to the “masking” of
lipids during sample preparation and performance of MALDI-MSI.
The MALDI image is generated pixel-by-pixel, by a laser rastering across the surface of a
tissue. At each distinct spatial location on the tissue, the laser causes desorption and
ionization of all the analytes at that location. In addition to lipids, tissue-associated salts and
buffers are also desorbed. Each pixel on a MALDI image is a complete mass spectrum of
everything detected at that one spatial location. A summation of many locations can provide
regional spectra (for example, the brain region images in figure 1) or even a total spectrum
for the entire tissue section. This total spectrum can thus be compared to the species detected
from total lipid extracts of a serial section.
Instead of the location-oriented method used by MALDI-MSI, ESI-LC-MS of total lipid
extracts separates lipids by their characteristic hydrophobic/hydrophilic class properties, in
which the specific elution profiles are dictated by the choice of solid support and solvent
system utilized. As a result, lower-abundance classes of lipids, such as CL, can be analyzed
without interference from other more highly abundant lipids, thus improving the overall
signal intensity of the CL species.
The issue of abundance is critical to any MS method, including MALDI-MSI. Those species
that exist in higher abundance will preferentially dominate the spectrum, with the lower
abundant species being barely detectable above the noise level. This is especially true with
regard to lipid oxidation products. In model systems containing a purified, single lipid
species, the diverse oxidation products produced will exist in readily detectable amounts.
However, in biological systems, the oxidative stress insults trigger peroxidation reactions in
multiple species resulting in the very minor amounts of oxidized lipid products of a
particular type. These three factors (a wide variety of oxidizable molecular species, the low
abundance of oxidation products, and the wide variety of possible oxidation products from
each oxidizable species) make MALDI-MSI quantification of any oxidized lipid species
even more challenging.
While MALDI-MSI is unique to other traditional MALDI techniques in its ability to
generate both molecular and spatial information within a tissue sample, it is not surprising to
find that it detects fewer species of lipids than its ESI-LC-MS counterpart. Analyte
accessibility and abundance are two of the greatest challenges that MALDI-MS faces in
order to perform as well as ESI-LC-MS. These issues can result in ion and signal
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suppressions during analysis. A variety of means have been used to overcome these
challenges including improved methods of tissue preparation and MS instrumentation.
3.2 Overcoming the limitations of MALDI-MSI abundance and coverage through sample
preparation
Depth of coverage for MALDI-MSI has been an ongoing question since the discovery that
analytes from within the tissue interior can be extracted towards the surface during sample
preparation and subsequently analyzed (Crossman et al., 2006). Phospholipid standards
applied to a sample holder prior to tissue overlay have been successfully analyzed by
MALDI-MSI after migration through the tissue (Landgraf et al., 2011). This demonstrates
that a degree of extraction can occur either during matrix application or immediately prior to
it. This extraction improves the signal intensity of phospholipids. Methods of matrix
application and the addition of a recrystallization or rehydration step afterwards have been
used to optimize the extraction of analytes (Bouschen et al., 2010) (Yang and Caprioli,
2011) (Thomas et al., 2012). Dry-coating of the matrix onto the tissue results in no real
extraction, but this can be improved with a subsequent recrystallization step (Puolitaival et
al., 2008). Some preparation methods even involve pre-coated slides in which the matrix is
applied before the tissue, and is subsequently extracted to the surface (Grove et al., 2011).
Partial laser ablation has been used to give some degree of depth profiling of tissues
(Milasinovic et al., 2012). The ultimate extension of the analyte migration paradigm is to
perform a series of lipid micro-extractions across the tissue surface, and analyze these
discrete extracts by MS to generate a lipid image (Kertesz and Van Berkel, 2010)
(Stegemann et al., 2011). This approach avoids the limitations of MALDI and matrix
application. It also allows LC-MS to be performed at each discrete location, albeit at a
significant worsening of spatial resolution as compared to MALDI-MSI (hundreds of
microns as opposed to tens of microns or better with the latter).
MALDI profiling has been used to detect some lower-abundance species. It is different from
MALDI-MSI in that a relatively large droplet (nanoliters) of matrix solution is applied to an
area of tissue, and that whole area is analyzed by the summation of many laser shots
(Jackson et al., 2005), Obviously, the spatial resolution is limited by the droplet size and is
significantly worse than other techniques of matrix application such as sublimation or
automated picoliter spotting (Hankin et al., 2007) (Aerni et al., 2005) (Delvolve and Woods,
2011). However MALDI profiling does strongly promote analyte extraction and
incorporation into the matrix. MALDI profiling has been used for direct analysis of CL in
rat tissue section (Wang et al., 2007). The tissues analyzed in that study were ones that were
abundant in CL and exhibited very little molecular diversity. In contrast, CL in the brain and
in oxidative injury models exhibits wide diversity (Tyurina et al., 2010) (Bayir et al., 2007).
Tissue pretreatment with a series of aqueous washes is one other method to reduce
interference from tissue salts and buffers (Angel et al., 2012). Significant improvement in
signal intensity and the number of lipid species observed has thus resulted from the removal
of compounds that could produce in-source suppression. Phosphatidylcholine is present in
large amounts in cellular membranes, and somewhat suppresses the signals of other PLs
(Schiller et al., 2002). It is noteworthy that it suppresses signals in negative mode spectra
even though PC is not normally detected in that mode. Another adverse effect is that in
positive mode it will form a variety of homo- and hetero-dimers with other PC species and
with PE, resulting in strong peaks in the same m/z 1400-1600 range where CL signals
appear (Eibisch et al., 2011). As mentioned above (section 2.3), pre-treatment of samples
with PLC removes the headgroup of phospholipids by cleavage at the glycerol-
phosphodiester bond. Different sources of PLC will have different specificity for
phospholipid substrates, and some sources (such as Clostridium bifermentans) are specific
exclusively for PC (Ramrakhiani and Chand, 2011). Application of this enzyme to a tissue
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section will convert PC into DAG by removal of the phosphocholine headgroup, and thus
help unmask signal from other, less abundant phospholipids, including CLs, in MALDI-
MSI.
Imaging with tandem mass spectrometry in MS/MS or multiple-stage tandem mass
spectrometry (MSn) uses fragmentation to help resolve the problem of isobaric and isomeric
species (Garrett et al., 2007) (Garrett and Yost, 2010). Unfortunately MALDI-TOF can only
examine one narrow mass window at a time in that mode (Wang et al., 2008). Thus it would
require either re-imaging a section (Garrett et al., 2007) or preparing an additional tissue
section in order to generate a comprehensive MALDI-TOF-MS/MS image. As such, it could
require many sections and long instrumental run times to perform extensive MS/MS
imaging. Despite this, MALDI-MS/MS and MSn is an excellent approach to identify
isobaric species from MSI and quantify their compositions.
Another promising approach to more completely detect a greater variety of phospholipids is
through the employment of a combination of serial sections for MALDI-MSI and ESI-LC-
MS. Total lipid extracts can be performed on entire tissue section or microdissected areas
thereof (Burnum et al., 2009) (Axelsen and Murphy, 2010) (Delvolve et al., 2011) (Hankin
and Murphy, 2010). Tissue salts, buffers, and other non-lipid components are removed as
part of the extraction. The lipid distribution of a section of tissue will be the same as both of
its serial sections. With these assumptions, a direct comparison of ESI-LC-MS and MALDI-
MSI data can be made to enrich the information on the diversified lipids, particularly those
present in low abundance (Koeniger et al., 2011). ESI-LC-MS can be performed, where the
effluent from a liquid chromatography column is fed directly into an ESI-MS instrument.
Split-flow LC-MS allows fractions to be collected simultaneously with ESI-MS analysis.
3.3 Ion suppression and isobaric species
One other advantage of LC-MS is separation of isobaric and isomeric species (Minkler and
Hoppel, 2010) (Kim et al., 2011). Depending on the limitations of the mass analyzer used
for MALDI-MSI, isobaric species of different lipid types may not be resolved and will be
detected as an ambiguous ion. Several phospholipid species are isobaric within the MALDI-
TOF instrument’s mass resolution limit, hindering identification by MALDI-TOF-MSI. A
similar issue is the presence of 13C isotope peaks that can be intense, due to the large
amounts of carbon present in lipid species (Scherer et al., 2010). For example, in rat brain
PI(16:0/18:1) at m/z 835.5 (negative mode) is significantly less abundant than PS(18:0/22:6)
at m/z 834.5, and without prior separation would be masked within the A+1 isotope (m/z
835.5) of the latter.
Although MALDI-MSI cannot separate analytes prior to analysis, there are approaches that
utilize separation of the analytes after they are desorbed and ionized. Differentiating ions of
similar mass by ion mobility spectrometry (IMS) will greatly improve imaging data
(Jackson et al., 2008). But this of course only works when there are ions to be detected - ion
suppression by charge-competition at the source of ionization cannot be resolved by better
separation post-ionization. Employing IMS in-line improves MALDI-TOF-MSI coverage
and minimizes suppression of lower-abundance species (Jackson et al., 2007b) (Kiss and
Heeren, 2011). This gives one dimension of separation after ionization, separates lipids from
different classes with similar masses, and can even separate isomeric species from the same
class (Woods and Jackson, 2010).
Improving the mass analyzer on the MALDI instrument is one obvious method to resolve
isobaric species. ICR analyzers, Orbitraps, and other FT-MS instruments with high mass
resolution have been used successfully for MALDI-MSI of lipids (Burnum et al., 2009)
(Vidová et al., 2010b) (Landgraf et al., 2009). Of course, isomers cannot be resolved purely
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by mass resolution -- oxidizable PS(18:0/18:2) and non-oxidizable PS(18:1×2) both produce
ions at m/z 786.5285. One disadvantage of FT-MS is the longer acquisition times as
compared to TOF-MS. Orbitraps and ICR’s both function by trapping ions of a given m/z
range, and then measuring the induced current as the ions repeatedly pass a detector plate,
and this improved mass resolution requires longer measurement times (Gross, 2011). For
example, the FT-MS image of a small area of a brain section (fig 5) required approximately
8 hours to acquire with as compared with 2 hours for the TOF image of an entire brain
section in figure 3. However FT-MS can accumulate ions from many laser shots prior to
analysis and this allows the simultaneous analysis of one imaging location while the next
location is being scanned. Thus ions from only a select mass region of interest could be
trapped for analysis, further improving sensitivity of FT-MS or other trapping instruments.
3.4 Matrix improvement for MALDI-MSI
MALDI-MS analysis requires the sample to be dried or otherwise turned into a condensed
state, and is tolerant to some extent of tissue salts and buffers. As such, this combination
makes MALDI an attractive method of tissue imaging. MALDI requires a matrix compound
to be applied in large excess to the analytes of interest, although direct laser-desorption
imaging of intact phospholipids from tissue samples in the absence of matrix or
nanoparticles has been reported recently (Goodwin et al., 2011). The matrix is usually a
small organic molecule exhibiting a strong absorption at a particular laser wavelength. A
laser (usually in the UV range) is then pulsed across the sample. Just enough laser energy is
applied to desorb the matrix off the surface in a plume, carrying nearby molecules with it.
Rapid charge-transfer reactions take place within the plume during or immediately after
desorption (Gross, 2011), resulting in the ionization and subsequent detection of
phospholipid analytes. As of now, there is no one perfect matrix for lipid MALDI-MS or
MSI (Wang et al., 2008) (Kim et al., 2010) (Thomas et al., 2012). As per Fuchs et al. (2010),
MALDI-MSI matrices need to exhibit the following five characteristics: 1. Strong
absorbance of the laser energy at its emission wavelength; 2. Ability to promote the
ionization of analytes; 3. Stability under high vacuum; 4. Ability to promote the isolation of
ions and minimize cluster formation; and 5. Formation of a homogenous surface layer with
analyte incorporation. The matrix requirements for MSI are even more stringent than for
non-imaging MALDI analyses. It is easier to deposit a homogeneous layer of matrix onto a
metal MALDI target plate (for non-imaging) than it is onto a frozen tissue section. Analyte
extraction from the tissue and incorporation into the matrix is essential (see section 3.2
above). Different matrix formulations have been used for different MALDI analytes (Fuchs
et al., 2010) (Thomas et al., 2012). 2,5-dihydroxybenzoic acid (DHB) has often been used
for lipids, but others have been reported to be useful (Stübiger and Belgacem, 2007). 9-
Aminoacridine (9-AA) has been used for MALDI-MS analysis of phospholipids in the
negative mode (Sun et al., 2007) (Teuber et al., 2010), including analysis of CL (Sun et al.,
2008) (Lobasso et al., 2010) (Eibisch et al., 2011). In addition to organic matrix compounds,
gold and silver nanoparticles have been utilized for MALDI-MSI of lipids (Jackson et al.,
2007b) (Hayasaka et al., 2010). 10-N-Nonyl-acridine orange (NAO) is a commonly used
fluorescent stain for cardiolipin. Photo-active compounds that selectively bind to CL such as
nonyl-acridine orange may be potentially developed into useful matrices for improved MSI
(Sparvero et al., 2011).
3.5 Improving the spatial resolution of MALDI-MSI
The effective utilization of MALDI-MSI for “biochemical lipid microscopy” requires
sufficient spatial resolution. Analyte migration during matrix application can limit spatial
resolution (see section 3.2 above). The size of the laser footprint is another critical
limitation. Conventional MALDI-MSI instrumentation usually can achieve a spatial
resolution of ~30×30 microns (Chaurand et al., 2011) (Urban et al., 2011) (Aizikov et al.,
Sparvero et al. Page 13
Chem Phys Lipids. Author manuscript; available in PMC 2013 July 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
2011). While detailed information on lipids in different anatomical areas of organs and
tissues can be obtained by these MALDI-MSI protocols, single cell or intracellular
assessments are not possible. Recently several approaches have been developed to improve
the spatial resolution of MALDI-MSI. One of them is based on oversampling whereby a
laser beam is moved at a step of several microns with complete ablation (“bleaching”) of the
matrix in the analyzed area (Jurchen et al., 2005). Although both the previous and new
locations will be illuminated, there is only matrix in the new location. Thus only analytes
from the new location are detected. This is repeated over a whole tissue area to give
MALDI-MSI with spatial resolution approaching cellular level (less than 25μm). For this to
be possible, the matrix needs to be deposited as very fine surface particles. Sublimation of
organic matrices and sub-surface implantation of nanoparticle matrices have been used to
achieve the highest spatial resolution (Murphy et al., 2009) (Murphy et al., 2011a) (Jackson
et al., 2007b). A limitation of oversampling is that much greater acquisition times are
required. As with any high spatial resolution technique, improving the spatial resolution
results in more areas acquired (pixels in the image). Thus, improving the spatial resolution
by a factor of two would result in four times as many discrete areas analyzed, and would
increase the acquisition time by approximately a factor of four. Oversampling also requires
enough laser shots to ensure the matrix in a given area is completely ablated, and this
increase in number of laser shots can significantly increase the total acquisition time. For
example, the entire brain section in figure 3 required approximately 2 hours to acquire,
while the much smaller oversampling areas in figure 6 required 4 hours
A variant of this approach is continuous laser rastering, in which the laser is fired
continuously as the sample stage moves, resulting in a continuous series of laser shots across
the tissue section (Spraggins and Caprioli, 2011). This is different from other methods of
MALDI-MSI where the laser is fired on discrete locations in between movements of the
sample stage. One other approach is to use microinjection of a matrix solution on top of or
directly into individual cells (Boggio et al., 2011). Microinjection does allow individual cells
to be targeted for MALDI analysis. However its disadvantage is the difficulty in preparing a
whole anatomical area for MALDI-MSI (such as the CA3 or dentate gyrus in the rat brain),
while sublimation can prepare an entire tissue section in a matter of minutes.
Two other approaches allow MSI of lipids without the need for added matrix - laser
desorption from tissue sections mounted to a nanostructure surface and desorption
electrospray ionization (DESI). Nano-assisted laser desorption/ionization (NALDI) and
Nanostructure initiator mass spectrometry (NIMS) are surface-assisted methods that use
nano-structured support surfaces to absorb laser energy and thus do not require matrix to be
added for desorption of analytes (Northen et al., 2007) (Greving et al., 2010). A recent
NALDI-MSI work (Vidová et al., 2010a) impressed a tissue section onto the surface
followed by MSI analysis of the imprint, thus identifying many prominent lipids with their
spatial localization. DESI scans a sample with a spray of charged droplets, resulting in
desorption and ionization of tissue analytes without a laser or matrix. This has been used to
image lipids in a wide variety of tissue types (Eberlin et al., 2011a). DESI can be combined
with subsequent MALDI-MSI, and this provides information on the co-localization of lipid
and protein species within a single tissue section (Eberlin et al., 2011b).
Secondary-ion mass spectrometry (SIMS) is utilized for very high spatial resolution MSI
(Passarelli and Winograd, 2011) (Benabdellah et al., 2010). This MS technique utilizes an
ion beam as opposed to a laser-matrix combination in order to desorb and ionize analytes
from a surface (Brunelle and Laprévote, 2009) (Touboul et al., 2011). Since SIMS does not
require a matrix, there are no issues related to its chemical properties and the method of its
deposition. An ion beam can be focused much tighter than a laser, thus the spatial resolution
of SIMS is an order of magnitude better than MALDI. This has allowed single-cell imaging
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and the elucidation of subcellular lipid biology, as reviewed by Passarelli and Winograd
(2011). For some lipid classes SIMS can produce images of comparable spectral quality to
MALDI-MSI, however at much better spatial resolution (Wang et al., 2008) (Fernandez-
Lima et al., 2011). SIMS can be utilized in static mode for surface analysis only or dynamic
mode, and the latter allows depth profiling of tissue sections (Fletcher et al., 2011). However
the high energies of the ion beam as presently used for SIMS can cause uncontrollable
fragmentation of higher-mass lipid analytes (particularly CLs), and thus have been limited in
practice to species of about 1000 Da or less (Debois et al., 2009).
3.6 Application of MALDI-MSI in different tissues
Comparison of progress in MALDI-MSI in lung versus brain reveals complexities and
subtleties that arise from discrete structural, functional, biochemical and anatomical
differences. As noted, the most progress in MALDI-MSI of lipids has been achieved with
brain sections. This is primarily due to the frozen brain tissue being relatively amenable to
microscopic examination after cryostat sectioning. Such preparation preserves structure
without the need for embedding and fixation. In contrast, lung usually requires inflation,
embedding and fixation with compounds that have proven incompatible with most forms of
MALDI-MSI. In contrast to protein imaging, limited work has been done on lipid imaging
of formalin-fixed tissues (Carter et al., 2011). Only recently has an embedding compound
compatible with MALDI-MSI of lipids been developed for the lung (Berry et al., 2011).
This methodology may be critical for a heterogeneous organ like lung devoid of large and
approachable anatomic tracts of associated function as in brain. In this regard, we were
gratified by our initial progress with analysis of unembedded frozen sections for
preservation of tissue architecture (fig. 8). Additional specific issues in lung include the
large abundance of phospholipids present as surfactant (primarily PG and PC) secreted into
airways with the potential to obscure identification of more minor species. In this regard, we
are encouraged by our ability to dilute such surfactants via lavage. Our focus on a low
abundance phospholipid, CL, and its oxidized species truly underscores the sensitivity of
MALDI-MSI. The close correlation of individual species of CL between MALDI-MSI and
ESI-MS add further confidence to the approach. The capacity to discern (fig. 8) oxidation of
CL within a region of the lung selectively affected by intratracheal delivery of potent free
radical generating system (glucose oxidase) suggests that additional efforts in enhancing
resolution (such as oversampling) may ultimately facilitate resolution to distinguish subtle
biochemical events within distinct and important anatomic compartments of lung that
structurally appear in close proximity with each other (e.g. endothelium and epithelium,
etc.).
3.7 Conclusions
Despite its drawbacks, MALDI-MSI is a unique MS methodology that has the ability to
generate both molecular and spatial information within a tissue section. While a specific
biomarker, be it lipid or protein, may be evident using traditional ESI-LC-MS methods, the
spatial confinements within normal or the diseased tissue will only be recognized with
MALDI-MSI. We believe that we have aptly demonstrated this in several relevant
paradigms addressing both the brain and the lung. The potential value of this approach in
diseases such as TBI cannot be understated, given the fact that heterogeneous regional
disturbances in the injured brain mandate methods that can map the lipid derangements to
understand their contribution to neuronal injury and develop targeted therapies. This unique
biochemical lipid microscopy may lead to new discoveries of the specific lipid biomarkers
associated with area-specific alterations or damage under stress/disease conditions. As with
any other newly emerging field, MALDI-MSI still has significant limitations and future
optimization work aimed at improvements of its spectral and spatial resolution, sensitivity
and specificity towards low abundance species of lipids is warranted.
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4. MATERIALS AND METHODS
4.1 Tissue preparation
To demonstrate the capabilities of MALDI-MSI methods, we applied them to four separate
experimental paradigms, namely, 1) assessment of the normal mouse brain, 2) assessment of
the naïve and injured (by experimental traumatic brain injury (TBI) induced by controlled
cortical impact (CCI)) immature (17 day old) rat brain, 3) assessment of the adult rat brain
after i.p. injections with docosahexaenoic acid (DHA), and 4) assessment of mouse lung
after acute lung injury (ALI). All procedures were pre-approved and performed according to
the protocols established by the Institutional Animal Care and Use Committee of the
University of Pittsburgh. Three naïve mouse brains were analyzed by MSI and LC-MS, and
in each experimental condition the number of control and treated/challenged animals were
as follows: CCI: 6 sham, 2 injured; DHA: 3 naïve, 2 treated. Immature (pnd 17) male
Sprague Dawley rats were exposed to CCI as described previously (Bayir et al., 2007) (6-
mm impactor tip, velocity of 4 ± 0.2 m/s, deformation depth of 2.5 mm, impact duration of
50 msecs) and sacrificed 2 hours after CCI. Adult Sprague Dawley rats were given DHA
(16mg/kg) intraperitoneally (i.p.) for 3 days prior to sacrifice. This dose was chosen since
when administered i.v. it significantly improved the neurologic outcome compared with
vehicle-treated Sprague Dawley rats in a stroke model (Belayev et al., 2009). For the acute
lung injury model, 6 control and 2 injured animals were studied. Acute lung injury (ALI)
was created in C57B6 mice by intratracheal injection of 40μl of enzyme solution (4.4 units
glucose oxidase (Sigma-Aldrich, St. Louis, MO, USA) plus 0.25 units lactoperoxidase
(Sigma-Aldrich, St. Louis, MO, USA) in Hank’s balanced salt solution (HBSS, Life
Technologies, Carlsbad, CA USA)) along with substrate (5.5 mM D-Glucose present in the
HBSS) in anesthetized (1% isoflurane in air), intubated, spontaneously breathing mice
(Johnson et al., 1981). At 3 hr after injury, mice were killed with overdose of sodium
pentobarbital, chest-opened and lungs perfused through heart and inflated with phosphate-
buffered saline (PBS, Life Technologies, Carlsbad, CA) by trachea. Brains or lungs were
harvested from these animals and immediately frozen in liquid nitrogen with neither fixation
nor embedding, and stored at −80°C until sectioning. Lungs prepared for oversampling MSI
were embedded in a modified embedding compound (Berry et al., 2011) prior to freezing.
Tissue was affixed to a cryotome block with minimal Tissue-Tek OCT (Sakura FineTek
USA, Torrance CA, USA). The blade and working surfaces of the cryotome were cleaned
with methanol immediately prior to cutting, and at no time did the blade come into contact
with OCT. Coronal brain sections of the dorsal hippocampus were cut at 10μm thickness at
−19°C, while lung sections were 12μm and −22°C. Tissue sections were applied to cold
histology slides pre-coated with a conductive indium tin oxide (ITO) surface (Delta
Technologies LTD, Loveland, CO, USA). The slides were immediately dried under house
vacuum for at least 1h and prepared for subsequent MALDI-MSI as described in section 4.2
below. Two serial sections were cut for each MALDI-MSI experiment (one each for positive
and negative mode). Sections bracketing this set of two serial sections were cut and applied
to plain glass slides for conventional histology and total lipid extraction. This set of sections
on plain glass bracketing sections on conductive ITO slides was repeated at least three
additional times, representative examples are presented for each.
4.2 LC and MS
Chloroform (HPLC grade), DHB (98+% grade) and KCl (reagent grade) were purchased
from Sigma-Aldrich (St. Louis, MO, USA). Methanol, trifluoroacetic acid (TFA),
triethylamine, acetic acid were all LC-MS grade from Fisher Scientific (Pittsburgh, PA,
USA). Water for LC use was LC-MS grade purchased from Fisher Scientific (Pittsburgh,
PA, USA); water for other uses was purified by a milliQ system (EMD Millipore, Billerica,
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MA, USA). Phospholipid standards including phosphatidylcholine (PC(11:0×2)),
phosphatidylserine (PS(17:0/17:0)), phosphatidylinositol (PI(16:0/16;0)),
phosphatidylglycerol (PG(12:0×2)), sphinomyelin (SM(d18:1/12:0)) and cardiolipin
(CL(14:0×4), CL(18:1×4), CL(18:2×4)) were purchased from Avanti Polar Lipids
(Alabaster, AL, USA) and diluted to 20μM in 2:1 chloroform/methanol. Lipid standards and
total lipid extracts were prepared for MALDI-MS in 2:1 chloroform: methanol by dried
droplet method with 200mM DHB.
Lipid extraction from en bloc tissue and thin tissue sections on glass slides was performed
with modified Folch method as described previously (Tyurina et al., 2011). Separation of
individual phospholipid classes was accomplished by normal phase chromatography on a
silica column (Luna 5μm, 25cm × 2 mm i.d., Phenomenex, Inc., Torrance, CA, USA) and
analyzed on a Waters Premier quadrupole time-of-flight (Q-TOF) mass spectrometer
(Waters, Inc., Milford, MA, USA) previously described (Samhan-Arias et al., 2012). Tuning
was optimized for all lipids across the scan range and data was collected in centroid mode.
Select tissue sections were incubated prior to matrix application with 50μl of PC-specific
phospholipase-C (PLC) from Clostridium bifermentans (Sigma-Aldrich, St. Louis MO,
USA) at 3.3 mU/ μl for 20 min at 25°C. The PLC solution was then carefully pipetted off,
followed by two brief (5 sec.) washes with ice-cold water. The tissue was vacuum dried
overnight. PLC digestion of lipid standards indicated that these conditions gave a strong
reduction in PC with no noticeable difference in CL (data not shown).
Matrix for MALDI-MSI was applied to sections with either solution application (Wang et
al., 2008) or sublimation (Hankin et al., 2007) (Murphy et al., 2011a). Solution application
of the MALDI matrix (55.0 mg/ml DHB in aqueous 70%/0.02% methanol/TFA) was
accomplished using a commercial airbrush (two bursts of 1 sec. duration per minute, a cycle
of 15 min. of spraying followed by 15 min. of vacuum drying repeated three times).
Sublimation application of DHB was used to prepare sections for high-spatial resolution
imaging. A modified sublimation chamber (Chemglass, Vineland NJ, USA) was used to
deposit the matrix onto the slides as per (Murphy et al., 2011a) (350mg DHB, 4°C
condenser). Prepared slides were stored at −80°C prior to analysis and allowed to equilibrate
to ambient temperature for 1hr while under house vacuum immediately prior to MALDI-
MSI. Serial sections were examined with hematoxylin and eosin (H&E) staining for
correlation of histological features with MALDI images. In the oversampling experiment,
the actual tissue section from the MALDI-MSI was subsequently used for H&E staining
after remaining matrix was carefully washed off with absolute ethanol.
Time-of-flight (TOF) MALDI -MS and –MSI were performed using Bruker Ultraflex II and
Autoflex TOF/TOF mass spectrometers (Bruker Daltonics, Billerica, MA, USA), and high
mass resolution MSI was performed using a Solarix Fourier transform ion cyclotron
resonance (FT-ICR) mass spectrometer (Bruker Daltonics, Billerica, MA, USA). Negative
polarity was used for anionic lipids (PS, PI, PG, CL, and phosphatidic acid (PA)) and
positive polarity was used for the others. Reflector mode was used for all MALDI-TOF-MS
experiments. Laser power and analyzer parameters were optimized for phospholipid
detection in the m/z 400-2000 range. MALDI-MSI was carried out at a 50 μm and 200 μm
rasters for normal resolution and at 10 μm and 20 μm rasters for oversampling. Normal
MALDI-MSI was performed with 100 laser shots at 30% arbitrary power with partial
sample random-walking every 20 shots, while oversampling used 200 laser shots at 35%
power with no random-walking. In all cases the laser diameter value was set to “minimum”.
MSI images and average MS spectra for regions of interest were generated with the Flex
Imaging 3.0 software package (Bruker Daltonics, Billerica MA) at a window of +/- 0.2Da
(+/-0.02 for FT-MS) unless stated otherwise. Extracted ion images were presented as raw
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pixels without interpolation. Normalization to total ion count (TIC) was not performed since
it has been reported that this could, in feature-rich tissue such as brain, result in erroneous
ion abundances (Deininger et al., 2011). Identification of ions as a particular lipid species
was based solely on exact mass and comparison with species previously identified and
characterized by MS/MS (Bayir et al., 2007) (Tyurin et al., 2008a).
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PE Phosphatidylethanolamine
PC phosphatidylcholine
CL cardiolipin
PS phosphatidylserine
PI phosphatidylinositol
PG phosphatidylglycerol
PA phosphatidic acid
SM sphingomyelin
ST sulfatide
Cer ceramide
DAG diacylglycerol
TOCL 1,1′,2,2′-tetraoleylcardiolipin
TLCL 1,1′,2,2′-tetralinoleoylcardiolipin
PL phospholipid
PUFA polyunsaturated fatty acid or fatty acyl
DHA docosahexaenoic acid
4-HNE 4-hydroxynonenal
4-HHE 4-hydroxyhexenal
CCI controlled cortical impact
CA Cornu Ammonis
PND postnatal day
ALI acute lung injury
TBI traumatic brain injury
CNS central nervous system
DHB 2,5-dihydroxybenzoic acid
TFA trifluoroacetic acid
HBSS Hank’s balanced salt solution
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PBS phosphate-buffered saline
H&E hematoxylin and eosin
NAO 10-N-nonyl-acridine orange
PLC phospholipase-C
MS mass spectrometry
MS/MS tandem mass spectrometry
MSn multiple-stage tandem mass spectrometry
MSI mass spectrometry imaging
MALDI matrix-assisted laser desorption/ionization
FT-ICR Fourier transform ion cyclotron resonance
TOF time-of-flight
Q-TOF quadrupole time-of-flight
ESI electrospray ionization
LC liquid chromatography
ITO Indium tin oxide
TIC total ion count
9-AA 9-Aminoacridine
SIMS secondary ion mass spectrometry
IMS ion mobility spectrometry
ISD in-source decay
DESI desorption electrospray ionization
NALDI nano-assisted laser desorption/ionization
NIMS Nanostructure initiator mass spectrometry
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Highlights
Mapping of lipids by MALDI-MSI
Biochemical microscopy of DHA-containing lipids
MALDI-MSI of lipid oxidation products in acute lung injury
MALDI-MSI detection of lipid response to traumatic brain injury
MALDI-MSI detection of cardiolipin
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Fig 1.
MALDI-MSI images and regional spectra of adult mouse brain. “Heat map” MALDI-MSI
images of PI(38:4) (m/z 885.5, panel A) and ST(24:1) with a d18:1 sphingosine (m/z 888.5,
panel B) display localization to different regions of the brain. The white bar is 1000 microns
and the scale displays relative intensities with respect to the abundance of each ion. These
lipids correlate to specific brain structures (C) upon comparison with a serial H&E section
(D). Comparison of the averaged MALDI-MSI spectrum from the entire tissue slice (E-
black trace) with that of the hippocampus (E - red trace) and white matter (E - green trace)
shows that many other d18:1 sulfatide species including ST(24:1) are more abundant in the
white matter than the hippocampus, while the opposite is the case with several PI species
including PI(38:4). Various lipids from several classes were also detected (F). Several
species of ganglioside GM1 with d18:1 sphingosines exhibited different localization,
depending on the composition of their long chain base. MALDI-MSI images were acquired
in negative mode with an Ultraflex II.
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Fig 2.
Comparison MALDI-MS and ESI-LC-MS from pnd 17 rat brain. A: MALDI-MS of brain
total lipid extract barely detects some CL species predominantly as [M-2H+Na]− adducts.
Ganglioside GM1 at m/z 1545 obscures CL in this region. B: Split-flow LC-MS allowed
collection of this CL fraction and subsequent analysis by MALDI-MS resulting in more
species of CL detected, and these were mixtures of [M-H]− and [M-2H+Na]− adducts. C:
ESI-LC-MS of same total lipid extract detects 70 species of CL, and these were detected as
[M-H]− ions. D. On—tissue phospholipase C (PLC) treatment and subsequent washing
results in MALDI-MSI detection of several species of CL predominantly as [M-H]− ions.
The inset region is at 50× magnification. MALDI-MS and –MSI were acquired with an
Autoflex in negative mode and ESI-LC-MS with a Q-TOF in negative mode.
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Fig. 3.
MALDI-MSI of cardiolipin (CL) and other more abundant phosopholipids after on-tissue
phospholipase C (PLC) treatment. The white bar is 2mm and the scale displays relative
intensities with respect to the abundance of each ion. A: PI(38:4) m/z 885.5, B: ST(24:1) m/
z 888.5, C: GM1(d18:1/18:0)m/z 1544.8; D: CL(72:8) m/z 1447.9, E: CL(74:7) m/z 1477.9,
F: near-serial H&E section. MSI images were acquired with an Autoflex in negative mode.
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Fig. 4.
Identification of MALDI-MSI species at m/z 806.5 and m/z 834.5 with the aid of ESI-LC-
MS. MALDI-MSI rat brain images of the species m/z 806.5 (A) and m/z 834.5 (B) could
each be either PS or STspecies, or some combination of both. The white bar is 1 mm and the
scale displays relative intensities with respect to the abundance of each ion. A total lipid
extract of the serial section gives an ESI-LC-MS chromatogram (C) that separates PS and
ST. LC-MS from the PS fraction (D) and ST fractions (E) show that 806.5m/z is almost
entirely ST (arrows) and 834.5m/z is a mixture of PS and ST (arrows). MALDI-MS
(Autoflex) and ESI-LC-MS (Q-TOF) spectra were acquired in negative mode.
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Fig. 5.
FT-ICR MSI completely resolves isobaric rat brain species. Several lipid species from
various classes were detected at high mass resolution and their localizations correlated with
an H&E stain of the tissue section. The white bar is 1000 microns and the scale displays
relative intensities with respect to the abundance of each ion. Two sets of isobaric species
(m/z 806.5 and 834.5) were completely resolved. The ions at m/z 806.497 and m/z 806.545
representing PS(38:6) and ST(d18:1/18:0) were resolved from each other, as were the ions
at, m/z 834.528 and m/z 834.576 representing PS(40::6) and ST(d18:1/20:0), respectively.
Each of these isobaric pairs was overlaid on the same MALDI image, but at the same
absolute scale. Green pixels represented the PS species, and red represented the ST species.
This confirmed that the m/z 806 species consisted almost entirely of ST(d18:1/18:0), while
the m/z 834 species was mostly PS(18:0/22:6) but with a significant amount of
ST(d18:1/20:0). The summation MALDI-MSI spectrum from the entire image further
confirmed these results. MSI images were acquired with a Solarix in negative mode.
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Fig. 6.
Oversampling to improve the spatial resolution of MALDI-MSI. A: Optical image of an
H&E stain of rat brain after MALDI-MSI analysis of the regions of interest within the white
boxes. Mass Spectra were collected with oversampling in both 20 and 10 micron rasters
across the hippocampal area. B: MALDI-MSI image of three molecular species displaying
distribution across fine structures within the hippocampus. The white scale bar is 200
microns. Different color pixels represent different species, and stronger pixel intensities
indicate greater abundance with respect to each ion. Green: m/z 885.5 representing PI(38:4);
Blue: m/z 885.5 representing ST(d18:1/24:0); Red: m/z 1544.8
representingGM1(d18:1/18:0). C: MALDI mass spectrum approaching cellular resolution
(location indicated with arrows in panel A and inset region). White marks on H&E section
resulted from laser ablation of tissue at the center of each position. MSI images were
acquired with an Autoflex in negative mode.
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Fig. 7.
MALDI-MSI of adult rat brain tissue after DHA supplementation. Heat-map MALDI-MSI
of brains from naïve (A) and DHA-dosed (B) rats showed increase in the ion at m/z 834.5
which is partly composed of PS(18:0/22:6). The white bar is 2 mm and the heat map is
scaled to relative intensities with respect to the abundance of the ion at m/z 834.5. Both
images are presented at the same abundance scale. As such, 100% intensity represents the
highest intensity observed between both images. LC-MS profiles of CL extracts from naïve
(C) and DHA-dosed (inset) serial brain sections showed an increase in DHA-containing CL
marked with arrows – m/z 1570: CL(18:0)(20:4)(22:6×2); m/z 1592: CL(20:4×2) (22:6×2).
Overall 29% of naïve and 38% of treated brain CL contained DHA. MALDI-MSI (Ultraflex
II) and ESI-LC-MS (Q-TOF) spectra were acquired in negative mode.
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Fig. 8.
MALDI-MSI of mouse lung determines regional assignment of critical common
phospholipids and oxidation products of less abundant cardiolipin in acute lung injury
(ALI). MALDI-MSI of normoxic lung in negative mode (A) detected several phospholipids
but not cardiolipin. MALDI-MSI was performed at 50 micron spatial resolution and the
white bar is 500 microns. Averaged MALDI spectra (B) and MALDI-MSI images (C) of
lung tissue section treated with PLC from normoxic mouse detected CL clusters but not
oxidative species of CL. MALDI-MSI was performed at 50 micron spatial resolution and the
white bar is 200 microns. ALI-model mouse lung MALDI spectra (D) and MALDI-MSI
images (E,F) in negative mode demonstrate decrease in CL content with detection of ions
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that corresponded in mass to beta-scission fragments of oxidized CL (m/z 1308, 1324, 1348,
and 1392 – see text for identification). Overlay image is of is m/z 1472 (green) and m/z
1348 (red). MALDI-MSI was performed at 50 micron spatial resolution and the white bar is
200 microns. MALDI-MSI of normoxic mouse lung in positive mode at 200 micron spatial
resolution (G) detects a variety of lipids. The white bar is 2000 microns. Among the species
detected were PC(16:0/16:0) and PC(16:0/22:6) as [M+H]+ ions at m/z 734.5 and m/z 806.6,
respectively. MALDI-MSI with oversampling of a small area of the same lung at 20 micron
resolution (H) and comparison with light microscopic H&E histology identified distinct
regional distributions of these two species. Overlay of the two ions (green: m/z 734.5, red:
m/z 806.6) in confirms this pattern. The white bar is 100 microns. MSI images were
acquired with an Autoflex in negative mode (A), Ultraflex in negative mode (B-F), and
Autoflex positive mode (G and H). All image scales depict relative intensities with respect
to the abundance of each ion.
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Fig. 9.
MALDI-MSI of pnd 17 rat brain after trauma. MALDI-MSI in negative mode shows
different distributions of m/z 806.5 that contains nonoxidizable ST(d18:1/18:0) (A) and m/z
834.5 that containsoxidizable PS(18:0/22:6) (B) in brain after controlled cortical impact.
Region of damage is shown by an arrow on serial H&E (C). The white bar is 200 microns
and the scale displays relative intensities with respect to the abundance of each ion. While
m/z 806.5 was detected in similar abundances between the hemispheres ipsilateral and
contralateral to the point of impact, m/z 834.5 is somewhat reduced in the ipsilateral cortical
and hippocampal regions with respect to the contralateral regions. MALDI-MSI in positive
mode detected different abundances of PC(16:0/16:0) adducts between both hemispheres.
While the [M+H]+ ion at m/z 734.5 (D) was detected in similar abundance ipsilateral and
contralateral, the [M+Na]+ adduct ion at m/z 756.5 (E) was in greater abundance ipislateral
while the [M+K]+ adduct ion at m/z 772.5 (F) was in greater abundance contralateral.
Negative mode and positive mode MSI images were acquired with an Autoflex.
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Table 2
Major CL species in pnd 17 rat brain. These 70 individual molecular species were detected as [M-H]- ions by
ESI-LC-MS and as [M-2H+Na]- ions at a correspondingly greater m/z value by MALDI-MS and -MSI. If a
species was previously characterized by MS/MS, its acyl chain compositions are given along with the
reference: [1] = (Tyurin et al., 2008); [2] = (Bayir et al., 2007). Abundance is the relative abundance among all
CL species detected as determined by ESI-LC-MS.
Species
[M-H]-
m/z Abundance Acyl chains Reference
CL(64:4) 1343.94 0.2% (C16:1)4 [2]
CL(64:3) 1345.91 0.2%
CL(64:2) 1347.92 0.2%
CL(66:6) 1367.89 0.2%
CL(66:5) 1369.93 0.3%
CL(66:4) 1371.94 0.5% (C16:1)3/(C18:1)1 [2]
CL(66:3) 1373.96 0.5% (C14:0)1/(C16:1)1/(C18:1)2 [1]
CL(66:2) 1375.97 0.4%
CL(66:1) 1377.97 0.2%
CL(68:7) 1393.94 0.4% (C16:1)3/(C20:4)1 [2]
CL(68:6) 1395.95 0.6%
CL(68:5) 1397.97 0.9% (C16:1)2/(C18:1)1/(C18:2)1 [2]
CL(68:4) 1399.98 1.5% (C16:1)2/(C18:1)2 [2]
CL(68:3) 1401.99 1.2% (C16:1)1/(C16:0)1/(C18:1)2 [1] [2]
CL(68:2) 1404.01 0.7% (C16:1)1/(C16:0)1/(C18:1)1/(C18:0)1; (C16:0)2/(C18:1)2 [1] [2]
CL(68:1) 1406.02 0.3%
CL(70:9) 1417.93 0.2%
CL(70:8) 1419.95 0.7%
CL(70:7)* 1421.97 1.8% (C16:1)1/(C18:2)3 [2]
CL(70:6)* 1423.98 2.1%
(C16:1)1/(C18:1)1/(C18:2)2;
(C16:0)1/(C16:1)1/(C18:1)1/(C20:4)1 [1] [2]
CL(70:5)* 1426.00 2.6% (C16:1)1/(C18:2)1/(C18:1)2 [1] [2]
CL(70:4)* 1428.02 3.1% (C16:1)1/(C18:1)3 [1] [2]
CL(70:3)* 1430.03 1.7%
CL(70:2) 1432.04 0.6% (C16:0)1/(C18:0)1/(C18:1)2 [2]
CL(70:1) 1434.04 0.3%
CL(72:10) 1443.95 0.8%
CL(72:9) 1445.97 1.5%
(C16:1)1/(C18:1)1/(C18:3)1/(C20:4)1;
(C16:1)1/(C16:0)1/(C18:3)1/(C22:5)1 [2]
CL(72:8)* ** 1447.99 3.6%
(C18:2)4; (C16:1)1/(C18:1)1/(C18:2)1/(C20:4)1;
(C16:0)1/(C18:1)1/(C18:3)1/(C20:4)1& [1]
CL(72:7)* ** 1450.00 4.8% (C18:1)1/(C18:2)3; (C16:1)1/(C18:1)1/(C18:2)1/(C20:3)1 [1]
CL(72:6)* ** 1452.02 4.4% (C18:1)2/(C18:2)2; (C16:1)1/(C18:1)2/(C20:3)1 [2]
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Species
[M-H]-
m/z Abundance Acyl chains Reference
CL(72:5)* ** 1454.03 4.4% (C16:0)1/(C18:1)2/(C20:3)1; (C18:1)3/(C18:2)1 [2]
CL(72:4)* 1456.05 3.3% (C18:1)4; (C16:0)1/(C18:1)2/(C20:2)1 [2]
CL(72:3) 1458.05 1.3%
CL(72:2) 1460.02 0.4%
CL(74:12) 1467.97 0.4%
CL(74:11)* 1469.97 1.7%
CL(74:10)* 1471.99 3.1%
CL(74:9)* ** 1474.00 4.5%
(C18:1)1/(C18:2)2/(C20:4)1;
(C16:0)1/(C18:1)1/(C18:2)1/(C22:6)1 [2]
CL(74:8)* ** 1476.02 5.1%
(C16:1)1/(C18:1)2/(C22:5)1;
(C16:1)1/(C18:2)1/(C20:3)1/(C20:2)1; (C16:0)1/(C18:1)2/(C22:6)1; (C16:0)1/(C18:1)1/(C20:4)1/(C20:3)1;
(C18:1)2/(C18:2)1/(C20:4)1 [1] [2]
CL(74:7)* ** 1478.03 4.2% (C18:1)3/(C20:4)1; (C16:1)1/(C18:2)1/(C20:3)1/(C20:1)1& [2]
CL(74:6)* 1480.05 2.3%
(C18:1)2/(C18:0)1/(C20:4)1; (C16:0)1/(C18:1)1/(C20:4)1/(C22:4)1;
(C16:0)1/(C18:0)1/(C20:4)1/(C22:5)1 [2]
CL(74:5) 1482.06 1.0%
CL(74:4) 1484.03 0.5%
CL(76:14) 1491.96 0.3%
CL(76:13) 1493.98 0.7% (C16:1)1/(C18:2)1/(C20:4)1/(C22:6)1 [2]
CL(76:12)* 1495.99 2.2% (C16:1)1/(C18:2)1/(C20:3)1/(C22:6)1 [2]
CL(76:11)* ** 1498.00 3.3% (C18:1)1/(C18:2)1/(C20:4)2 [1] [2]
CL(76:10)* ** 1500.02 3.8% (C18:1)2/(C20:4)2; (C18:0)1/(C18:2)2/(C22:6)1 [1] [2]
CL(76:9)* ** 1502.03 3.1%
(C18:1)2/(C20:4)1/(C20:3)1;
(C16:0)1/(C18:1)1/(C20:4)1/(C22:4)1 [1] [2]
CL(76:8)* 1504.05 1.7%
(C18:1)1/(C18:2)1/(C20:3)1/(C20:2)1;
(C16:0)1/(C18:2)1/(C20:2)1/(C22:4)1
CL(76:7) 1506.06 0.8%
(C16:0)1/(C18:1)1/(C20:3)1/(C22:3)1;
(C16:0)1/(C18:0)1/(C20:1)1/(C22:6)1
CL(76:6) 1508.04 0.5%
CL(78:15) 1517.97 0.4% (C16:1)1/(C18:2)1/(C22:6)2 [1] [2]
CL(78:14)* 1519.99 0.9% (C18:2)1/(C20:4)3 [1]
CL(78:13)* 1522.00 1.6% (C18:1)1/(C18:2)1/(C20:4)1/(C22:6)1; (C18:2)1/(C20:4)3 [2]
CL(78:12)* 1524.01 1.9% (C18:1)2/(C20:4)1/(C22:6)1 [1] [2]
CL(78:11)* 1526.02 1.5% (C18:1)2/(C20:3)1/(C22:6)1 [2]
CL(78:10) 1528.03 1.0% (C18:1)2/(C20:4)1/(C22:4)1 [1]
CL(78:9) 1530.01 0.7%
CL(78:8) 1532.04 0.4%
(C16:1)1/(C18:1)1/(C20:3)1/(C22:3)1;
(C18:1)2/(C20:0)1/(C22:6)1 [2]
CL(80:16)* 1543.98 0.5%
CL(80:15)* 1545.98 0.8% (C18:1)1/(C20:4)2/(C22:6)1 [2]
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Species
[M-H]-
m/z Abundance Acyl chains Reference
CL(80:14)*
**
cl(80:13)* ** 1550.00 0.9%
(c18:1)1/(c18:0)1/(c22:6)2; (c18:1)2/(c22:5)1/(c22:6)1;
(c18:0)1/(c20:4)2/(c22:5)1; (c18:2)1/(c20:3)2/(c22:5)1 ;
(c18:2)1/(c18:0)1/(c22:5)1/(c22:6)1 [1] [2]
cl(80:12) ** 1551.99 0.7% (c18:0)2/(c22:6)2 [1] [2]
cl(80:11) 1554.01 0.6%
(c18:1)2/(c22:5)1/(c22:4)1;
(c18:1)1/(c18:0)1/(c22:4)1/(c22:6)1 [2]
cl(82:18) 1567.97 0.3%
cl(82:17) * 1569.96 0.5% (c18:1)1/(c20:4)1/(c22:6)2 [1] [2]
cl(82:16) * 1571.96 0.5% (c18:1)1/(c20:3)1/(c22:6)2 [2]
cl(82:15) 1573.96 0.5%
*
= detected by MALDI-MS
**
= detected by MALDI-MSI
&
= minor species
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